DYNC1LI2 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to DYNC1LI2 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Pembrolizumab (MK-3475) in MM Patients With Residual Disease	PHASE2	COMPLETED
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype	EARLY_PHASE1	COMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia	nan	COMPLETED
Diagnosis of Primary Ciliary Dyskinesia	nan	COMPLETED
Genetics of Primary Ciliary Dyskinesia	nan	COMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)	nan	COMPLETED
Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies	nan	COMPLETED
PCD New Gene Discovery	nan	COMPLETED
Mapping Disease Pathways for Biliary Atresia	nan	RECRUITING
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease	nan	RECRUITING
NIOX VERO Nasal Application in Primary Ciliary Dyskinesia	nan	COMPLETED
Early Detection and Characterization of Primary Ciliary Dyskinesia	nan	UNKNOWN
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve	nan	UNKNOWN
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease	nan	UNKNOWN
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia	nan	UNKNOWN
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies	nan	RECRUITING
Inherited Reproductive Disorders	nan	RECRUITING
Biomarker Research in Inherited Movement Disorders	nan	RECRUITING
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk	nan	NOT_YET_RECRUITING
Mapping Novel Disease Genes for Dilated Cardiomyopathy	nan	COMPLETED
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia	nan	RECRUITING
Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis	nan	COMPLETED
Muscle Tissue Bank for Muscular Dystrophy	nan	COMPLETED
Clinical Outcome Study for Dysferlinopathy	nan	UNKNOWN
CDH1 Germline Mutations in Lobular Breast Cancer	nan	COMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer	nan	UNKNOWN
Characteristics of Nondystrophic Myotonias	nan	COMPLETED
Core Stability Exercises and Hereditary Ataxia	nan	COMPLETED
Identification of New FTLD Genes	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a DYNC1LI2 binder may also engage these)

Protein	Name	Similarity
Q6PDL0	—	1.000	Q6PDL0 →
Q5RE09	—	1.000	Q5RE09 →
Q4R5P6	—	1.000	Q4R5P6 →
Q62698	—	0.992	Q62698 →
Q8R1Q8	—	0.986	Q8R1Q8 →
Q90828	—	0.982	Q90828 →
Q9QXU8	—	0.979	Q9QXU8 →
DYNC1LI1	Cytoplasmic dynein 1 light intermediate chain 1	0.975	landscape →
Q4KUS2	—	0.974	Q4KUS2 →
P58405	—	0.971	P58405 →
O43815	—	0.971	O43815 →
Q9ERG2	—	0.970	Q9ERG2 →
Q9UPT6	—	0.970	Q9UPT6 →
Q9Z1N9	—	0.969	Q9Z1N9 →
Q13033	—	0.967	Q13033 →
A5D7H2	—	0.967	A5D7H2 →
Q9ESN9	—	0.967	Q9ESN9 →
Q6PAL8	—	0.966	Q6PAL8 →
Q9ULQ0	—	0.966	Q9ULQ0 →
P70483	—	0.966	P70483 →
Q8CC27	—	0.966	Q8CC27 →
Q01826	—	0.966	Q01826 →
Q6EDY6	—	0.966	Q6EDY6 →
Q9UPW8	—	0.965	Q9UPW8 →
Q811S7	—	0.965	Q811S7 →
Q803T2	—	0.965	Q803T2 →
O60271	—	0.965	O60271 →
Q0P5J8	—	0.965	Q0P5J8 →
Q8C079	—	0.965	Q8C079 →
Q5VZK9	—	0.965	Q5VZK9 →